Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H P Volz

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Der Nervenarzt|February 1, 1988
[Electroconvulsive therapy-induced cardiac decompensation]H P Volz, M Linden
The British Journal of Psychiatry : the Journal of Mental Science|January 25, 2000
Lipid supplementation in schizophreniaI Maurer, H P Volz
Pharmacopsychiatry|January 1, 1997
Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trialH P Volz, M Kieser
Deutsche Medizinische Wochenschrift (1946)|August 25, 1995
[Moclobemide]C Gleiter, H P Volz
Der Nervenarzt|May 1, 1991
[Cardiovascular irregularities in schizophrenia--more than an epiphenomenon?]H P Volz, A Mackert
Pharmacopsychiatry|May 1, 1994
Antidepressant drug therapy in the elderly--a critical review of the controlled clinical trials conducted since 1980H P Volz, H J Möller
Drugs & Aging|November 26, 1998
Monoamine oxidase inhibitors. A perspective on their use in the elderlyH P Volz, C H Gleiter
Drugs|November 1, 1996
Drug treatment of depression in the 1990s. An overview of achievements and future possibilitiesH J Möller, H P Volz
Fortschritte Der Neurologie-Psychiatrie|January 29, 1999
[Opipramol in anxiety and somatoform disorders. Results of a controlled study]H P Volz, H J Möller
Deutsche Medizinische Wochenschrift (1946)|April 11, 1997
[Fluoxetine]C H Gleiter, H P Volz
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Der Nervenarzt|February 1, 1988
[Electroconvulsive therapy-induced cardiac decompensation]H P Volz, M Linden
The British Journal of Psychiatry : the Journal of Mental Science|January 25, 2000
Lipid supplementation in schizophreniaI Maurer, H P Volz
Pharmacopsychiatry|January 1, 1997
Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trialH P Volz, M Kieser
Deutsche Medizinische Wochenschrift (1946)|August 25, 1995
[Moclobemide]C Gleiter, H P Volz
Der Nervenarzt|May 1, 1991
[Cardiovascular irregularities in schizophrenia--more than an epiphenomenon?]H P Volz, A Mackert
Pharmacopsychiatry|May 1, 1994
Antidepressant drug therapy in the elderly--a critical review of the controlled clinical trials conducted since 1980H P Volz, H J Möller
Drugs & Aging|November 26, 1998
Monoamine oxidase inhibitors. A perspective on their use in the elderlyH P Volz, C H Gleiter
Drugs|November 1, 1996
Drug treatment of depression in the 1990s. An overview of achievements and future possibilitiesH J Möller, H P Volz
Fortschritte Der Neurologie-Psychiatrie|January 29, 1999
[Opipramol in anxiety and somatoform disorders. Results of a controlled study]H P Volz, H J Möller
Deutsche Medizinische Wochenschrift (1946)|April 11, 1997
[Fluoxetine]C H Gleiter, H P Volz
Pageof 9